Drug intelligence / Profile preview

glabridin

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Glabridin is a prenylated isoflavan isolated from the roots of Glycyrrhiza glabra (licorice), acting as a phytoestrogen and possessing diverse biological activities including anti-inflammatory, antioxidant, antimicrobial, anti-tumor, bone protective, neuroprotective, hepatoprotective, cardiovascular protective, anti-obesity, and anti-diabetes effects. Mechanistically, it modulates several signaling pathways (e.g., NF-κB, MAPK, Wnt/β-catenin, PI3K/AKT, AMPK), inhibits tyrosinase, P-glycoprotein, and CYP2E1, and activates peroxisome proliferator-activated receptor γ (PPARγ). It is a positive allosteric modulator of GABAA receptor, exerts platelet aggregation inhibition (implicating utility in thromboembolic disorders), and acts as a skin-whitening and cosmetic agent. Clinical use is limited by poor water solubility and bioavailability; efforts to improve delivery include nanoemulsions and microneedles[1][2][4][5][6][7].

Other names
glabridin(R)-4-(3,4-Dihydro-8,8-dimethyl-2H,8H-benzo[1,2-b:3,4-b′]dipyran-3-yl)-1,3-benzenediol1,3-Benzenediol, 4-(3,4-dihydro-8,8-diMethyl-2H,8H-benzo(1,2-b:3,4-b')dipyran-3-yl)-, (R)-(R)-isoflavanGlabridin/OIL SOLUBLE LICORICE(GLYCYRRHIZA) EXTRACTGlabridin/Propylene Glycol
02

Targets

ESR1 (ERα)ABCB1 (P-glycoprotein)PPARG (Peroxisome proliferator-activated receptor gamma)GABRR (GABA-A receptor subunit rho)CYP2E1TYR (Tyrosinase)

Beyond the preview

Go deeper on glabridin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on glabridin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call